Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Catalent Inc (NY: CTLT )

107.02 -0.27 (-0.25%)
Official Closing Price Updated: 7:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 821,160
Open 107.28
Bid (Size) 86.00 (1)
Ask (Size) 120.00 (1)
Prev. Close 107.29
Today's Range 105.98 - 108.81
52wk Range 86.34 - 142.64
Shares Outstanding 170,341,553
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Catalent, Inc. to Present at June Investor Conferences
From Catalent, Inc.
Via Business Wire
Quant Ratings Updated on 75 Stocks
I decided to revise my Portfolio Grader recommendations for 75 big blue chips -- of those 75, 24 stocks were updated to a buy. 
Via InvestorPlace

Performance

YTD
-14.03%
-14.03%
1 Month
-3.78%
-3.78%
3 Month
-5.63%
-5.63%
6 Month
-14.03%
-14.03%
1 Year
-5.42%
-5.42%

More News

Read More
Morgan Stanley Maintains Overweight Rating for Catalent: Here's What You Need To Know
Via Benzinga
Stocks Stage Midday Rally as Bond Yields Cool
Via Talk Markets
41 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
80 Biggest Movers From Yesterday
Via Benzinga
Catalent Shares Jump As Investors Cheer Revised, Better Than Expected FY22 Outlook
Via Benzinga
Recap: Catalent Q3 Earnings
Via Benzinga
Why Erytech Pharma Are Shares Moving Higher Today
Via Benzinga
Catalent, Inc. Reports Third Quarter Fiscal 2022 Results
From Catalent, Inc.
Via Business Wire
How To Attend Catalent Q3 2022 Earnings Conference Call
Via Benzinga
Catalent, Inc. Announces Third Quarter Fiscal Year 2022 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
24 Biggest Movers From Yesterday
Via Benzinga
Catalent's Q2 Earnings Beat Street View, Lifts FY22 Guidance
Via Benzinga
Expert Ratings For Catalent
Via Benzinga
Markets Fall As Investors Weigh March CPI Report
Via Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
Via Benzinga
Catalent, Inc. to Present at the KeyBanc Life Sciences & MedTech Investor Forum
From Catalent, Inc.
Via Business Wire
Novo Nordisk Doubles 2025 Sales Target On Strong Wegovy Demand
Via Benzinga
Executives Sell More Than $210M Of 5 Stocks
Via Benzinga
The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program
Via Benzinga
Catalent, Inc. Reports Second Quarter Fiscal 2022 Results
From Catalent, Inc.
Via Business Wire
A Bearish Sign Appears On Catalent's Chart
Via Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
Via Benzinga
Catalent, Inc. Announces Second Quarter Fiscal Year 2022 Earnings Conference Webcast
From Catalent, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account